Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis

April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, Kim Papp

Open source

DOI: 10.1001/jamadermatol.2024.2701
Published: 2024-10-01
Container: JAMA Dermatology
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2024.2701,
  title = {Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis},
  author = {April W. Armstrong and Melinda Gooderham and Charles Lynde and Catherine Maari and Seth Forman and Lawrence Green and Vivian Laquer and Xinyan Zhang and Nathalie Franchimont and Esha A. Gangolli and Jessamyn Blau and Yiwei Zhao and Wenwen Zhang and Bhaskar Srivastava and Graham Heap and Kim Papp},
  year = {2024},
  journal = {JAMA Dermatology},
  doi = {10.1001/jamadermatol.2024.2701},
  url = {https://doi.org/10.1001/jamadermatol.2024.2701}
}

RIS

TY  - JOUR
TI  - Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis
AU  - April W. Armstrong
AU  - Melinda Gooderham
AU  - Charles Lynde
AU  - Catherine Maari
AU  - Seth Forman
AU  - Lawrence Green
AU  - Vivian Laquer
AU  - Xinyan Zhang
AU  - Nathalie Franchimont
AU  - Esha A. Gangolli
AU  - Jessamyn Blau
AU  - Yiwei Zhao
AU  - Wenwen Zhang
AU  - Bhaskar Srivastava
AU  - Graham Heap
AU  - Kim Papp
PY  - 2024
JO  - JAMA Dermatology
DO  - 10.1001/jamadermatol.2024.2701
UR  - https://doi.org/10.1001/jamadermatol.2024.2701
ER  -

APA

Armstrong, A. W., Gooderham, M., Lynde, C., Maari, C., Forman, S., Green, L., Laquer, V., Zhang, X., Franchimont, N., Gangolli, E. A., Blau, J., Zhao, Y., Zhang, W., Srivastava, B., Heap, G., & Papp, K. (2024). Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.2701

Source records

crossref · retrieved 2026-09-25T13:06:22.556Z